Novel Coronavirus (SARS-CoV-2/COVID-19)

AHA urges all health plans to help maximize health care capacity for the COVID-19 emergency by suspending utilization management processes that delay or prevent patients from being transferred or discharged to clinically appropriate settings and covering the cost of care at these sites.
In the midst of the tragedy that is the COVID-19 pandemic, one silver lining is how it has brought us together as an organization to help us innovate and realize our vision to make Indiana one of the healthiest states in the nation.
The Department of Health and Human Services today will amend the Public Readiness and Emergency Preparedness Act to permit doctors and nurses who have recently retired or become inactive to administer COVID-19 vaccines and anyone currently licensed to vaccinate in their state to administer shots…
President Biden announced the federal government will purchase an additional 200 million doses of the two COVID-19 vaccines authorized by the Food and Drug Administration for emergency use.
The National Institutes of Health has launched an online data portal to collect clinical information on neurological symptoms, complications and outcomes related to COVID-19.
Regeneron Pharmaceuticals Inc. announced interim data indicating that its REGEN-COV antibody cocktail could be used as a passive vaccine to prevent COVID-19.
This year, I look forward to continuing AHA’s Leadership Rounds, short conversations on trending topics with health care leaders from around the country.
America’s hospitals and health systems have faced unprecedented financial pressures due to the COVID-19 pandemic.